// App-Quantinova.ai

OP0008 : DEVELOPMENT AND VALIDATION OF AN ALTERNATIVE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE WHEN PATIENT GLOBAL ASSESSMENT IS UNAVAILABLE

Researchers

Presenter

  • A. Ortolan

Principal Investigators

  • S. Ramiro

  • F. A. Van Gaalen

  • T. K. Kvien

  • R. B. M. Landew

  • P. M. Machado

  • A. Ruyssen-Witrand

  • A. Van Tubergen

  • C. Bastiaenen

  • D. Van der Heijde

Medical Centers

  • LUMC, Leiden, Netherlands

  • University of Pavia, Pavia, Italy

  • Zuyderland MC, N/A, Heerlen, Netherlands

  • Diakonhjemmet Hospital, Oslo, Norway

  • VUmc, Amsterdam, Netherlands

  • Kings College London, London, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Univ Hospital, Toulouse, France

  • MUMC, Maastricht, Netherlands

  • Maastricht University, Maastricht, Netherlands

Locations

  • Netherlands

  • Italy

  • Norway

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved